FDA Approves METFORMIN HYDROCHLORIDE — Ascend Laboratories, LLC
On November 1, 2010, Ascend Laboratories, LLC received FDA approval to market metformin hydrochloride oral tablets, paving the way for increased generic accessibility and leveraging generic competition to put downward pressure on diabetes treatment prices.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed